Shanghai New Asia Pioneer Pharmaceuticals CO., LTD was set up on the basis of the former Shanghai Pioneer Pharmaceuticals CO., Shanghai New Asia Pharmaceuticals CO., as well as Shanghai NO. 4 Pharmaceuticals CO. through transformation from debt to shares, reorganization of capitals. Chambers Yang has offered high-quality legal service for such transaction and was retained as the legal advisor for it.
相关法律服务
杨春宝一级律师简介
杨春宝一级律师，大成上海高级合伙人、资本市场部主任、国资基金研究中心主任，大成中国区私募基金专业带头人、科技与文化法律研究中心联合牵头人。执业30余年，长期从事私募基金、投融资、并购重组法律服务，尤其对对赌研究颇深且具有非常丰富的实战经验，并专注于金融机构股权投资业务。2004年起多次入选The Legal 500"私募基金"和"公司与商业"等境内外各类律师榜单，代理的中国法院首例适用外国法律审理外国公司的董事损害小股东权益纠纷案入选上海高院发布的《上海法院域外法查明典型案例》和威科先行"要案头条"。入选上海涉外法律人才库、上海市司法局鼎新法治人才库、上海国有企业改制法律顾问团，具有上市公司独立董事任职资格，系多家知名高校的兼职教授或兼职研究生导师及上海市商务委跨国经营人才培训班讲师。出版《私募股权投资基金风险防控操作实务》等16本投融资法律专著。了解更多常见法律问题
What is a debt-to-share transformation in a corporate restructuring?
A debt-to-share transformation converts a creditor's claims against a company into equity, reducing the company's debt burden and improving its balance sheet. It typically requires the consent of the creditor, a proper valuation of the converted debt, amendment of the company's articles of association and registration of the change of shareholders with the market regulation authority. For state-involved enterprises, additional approval and asset evaluation procedures may apply.
What legal issues arise when restructuring a pharmaceutical company in China?
Restructuring a pharmaceutical company in China involves both corporate and regulatory issues, including changes of shareholders and legal representative, transfer or renewal of the drug manufacturing license, compliance with GMP requirements, notification to or approval by the drug administration authority, arrangements for employees, contracts and intellectual property, and the continuity of product registrations. If the regulatory procedures are not handled properly, production and distribution may be interrupted.
Why does a restructured pharmaceutical company need a retained legal consultant?
After a restructuring, a pharmaceutical company faces ongoing compliance obligations in manufacturing, quality control, advertising, distribution contracts, data protection and regulatory filings. A retained legal consultant provides continuous legal support for these obligations and for future transactions, helping the company operate safely and avoid disputes, penalties and interruption of business.
以上内容仅供参考，不构成法律意见。如需专业法律服务，请联系杨春宝一级律师：chambers.yang@dentons.cn
